[responsive_menu_pro]

Publications

  1. Lim SY, Cengiz P. Opioid tolerance and opioid-induced hyperalgesia: Is TrkB modulation a potential pharmacological solution? Neuropharmacology. 2022 Dec 1;220:109260. [Review]
  2. Lim SY, May C, Johnson P, Miller L. Caffeine dosing in premature neonates: impact of birth weight on a pharmacokinetic simulation study. Pediatr. Res. Jun 2022. doi: 10.1038/s41390-022-02172-y. Epub ahead of print. PMID: 35717480. [Original research]
  3. Hintze T, Miller JL, Neely S, Lim SY, Gupta N, Johnson PN. Characterization of early versus late opioid iatrogenic withdrawal syndrome in critically-ill children transitioning from fentanyl infusions to methadone. J Opioid Manag. 2022. In press. [Original research]
  4. Lim SY. Opioid effects on the central nervous system and the peripheral immune system: implications for opioid tolerance. Current Pharmacology Reports. 2021;7: 81–95. https://doi.org/10.1007/s40495-021-00258-5 [Review]
  5. Harkin M, Miller JL, Lim SY, Neely S, Walsh C, Johnson PN. Conversion from Continuous Infusion Fentanyl to Continuous Infusion Hydromorphone in the Pediatric Intensive Care Unit. Annals of Pharmacotherapy. Mar 2021. Epub ahead of print. [Original research]
  6. Lim SY, Miller JL, Henry E, Heltsley R, Woo S, Johnson PN. Analysis of Fentanyl Pharmacokinetics, and its Sedative Effects and Tolerance in Critically-Ill Children. Pharmacotherapy. Feb 2021. doi:10.1002/phar.2515. Epub ahead of print. [Original research]
  7. Lim SY*, Lewis TV*, Woo S, Bourne DWA, Burton ME, Turman MA, Rianthavorn P. Daptomycin pharmacokinetics in adolescents undergoing hemodialysis and peritoneal dialysis: a case series with pharmacokinetic modeling. *Equal contribution. J Pediatr Pharmacol Ther. 2021;26(2):123-132. doi: 10.5863/1551-6776-26.2.123 [Original research]
  8. Salemi L, Sahlstrom A, Lim SY, Johnson PN, Dannaway D, Miller JL. Evaluation of the use of caffeine maintenance doses greater than 5 mg/kg/day in extremely preterm neonates for apnea of prematurity. (Accepted) 2020. J Pediatr Pharmacol Ther. [Original research]
  9. Lim SY, Miller JL. Ampicillin dose for early and late-onset Group B Streptococcal disease in neonates. Am J Perinatol. 2020 doi: 10.1055/s-0040-1718880 [Systematic review]
  10. Lim SY, Sharan S, Woo S.  Model-based meta-analysis of cannabidiol dose-exposure relationship and bioavailability.  Pharmacotherapy.2020; doi: 10.1002/phar.2377 [Original research]
  11. Lim SY, Woo S, Miller JL, Skrepnek G, Henry E, Johnson PN.  Prediction and comparison of fentanyl infusion pharmacokinetics in obese and non-obese children.  Pediatr Crit Care Med. 2019; 20(12):e556-e564. doi: 10.1097/PCC.0000000000002125  [Original research]
  12. Lim SY, Pettit R. Pharmacokinetic consideration in pediatric pharmacotherapy. Am J Health Syst Pharm. 2019; 76(19):1472-1480. doi: 10.1093/ajhp/zxz161 [Review article]
  13. Johnson PN, Stephen K, Barker P, Bergeron E, Lim SY, Hagemann T, Lewis T, Neely S, Miller JL. Prescribing patterns of continuous infusions in nonobese versus obese children admitted to the pediatric intensive care unit. J Pediatr Intensive Care. 2019 June 21. [Original research]
  14. Lim SY, Woo S, Miller JL, Lewis TV, Henry E, Johnson PN. Dosing for fentanyl infusion in obese children: Just because it’s what we have always done doesn’t mean it is right. J Pediatr Pharmacol Ther. 2018;23(3):223-226. [Letter to the editor]